Alec Kimmelman, MD, PhD, and Shridar Ganesan, MD, PhD, discuss the institution's new molecular oncology program.

Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University, State Key Laboratory for Digestive Health, National Clinical Research Center for Digestive Disease, Beijing ...

Mainly it is reserved for patients that have never smoked because small cell lung cancer, being a disease mainly in people that have smoked heavily, whenever we have a patient that has never smoked, ...

Lobular breast cancer LBC or invasive lobular carcinoma ILC is the second most common form of breast cancer but is often ...

The methylation of plasma cell-free DNA (cfDNA) has emerged as a valuable diagnostic and prognostic biomarker in various cancers including colorectal cancer (CRC). Currently, there are no biomarkers ...

Because of the availability of novel cancer treatments that specifically target tumor cells underlying signaling pathways, molecular characterization of CTCs has strong potential to translate into ...

Lung cancer remains the leading cause of cancer-related deaths globally, with cigarette smoking as its primary driver.

Molecular tests can improve the diagnosis of fungal infections. Despite the increasing application for fungal detection, molecular tests are still not accepted as a diagnostic criterion to define ...

Cancer is a leading cause of death worldwide but several ASX biotechs are focused on early detection and treatment to improve ...

They block the molecular pathways that are critical to tumor growth. These oral or intravenous (IV) administered drugs “target” cancerous cells or certain receptors on cancer cells without ...

UCLA Health’s Outpatient Theranostics Center allows clinicians to treat up to 16 patients per day with Pluvicto and other ...

Scientists at MedUni Vienna, led by Lukas Kenner, have made a groundbreaking discovery that could change how we understand ...